The North America interventional neurology devices market has accounted for USD 959 million in 2016 growing at the CAGR of 7.3% in the forecast period 2017 to 2024.
The North America interventional neurology devices market, the significant driving factors are growing obese and ageing population, technological developments in the interventional neurology market. The interventional neurology devices market growth is owing to factors such as rising incidence for hemorrhagic and ischemic stroke and rising demand for minimally invasive procedures for the treatment of neurovascular disease. According to the recent data of clinical trials, interventional procedures are more proffered as compared to neurosurgery as there is minimal damage to surrounding tissues, minimal surgical trauma, lesser possibility of infection in post-surgical phase and lesser surgical scar.
The North America interventional neurology devices market is segmented based on products, procedure, application, end-user and geography.
On the basis of product the interventional neurology devices market is segmented into aneurism coiling and embolization devices, angioplasty devices, neurothrombectomy devices and, micro support devices. The aneurism coiling and embolization device segment is further segmented into embolic coils, flow diversion device; liquid embolic device. The angioplasty devices product segment is further categorized into carotid artery stents and embolic protection systems. The micro support devices segment is further classified based on product types into microcatheters and microguidewires. The neurothrombectomy devices are further segmented into clot retrieval devices, suction and aspiration devices and, snares.
The market is further segmented based on procedures into embolization, angioplasty, neurothrombectomy and, others. The market is also segmented based on end-user into hospitals, neurology clinics, ambulatory care centers and, others.
Based on geography the North America interventional neurology devices market is segmented into 3 countries U.S. Canada and, Mexico. In 2015, the U.S. market dominates the North America market in terms of size and growth and is expected to continue the same trend in the forecast period 2016 to 2022.
The North America interventional neurology devices market report contains an in-depth profiling of the key market players, along with the recent developments (New product launches, partnerships, agreements, collaborations, and joint ventures) and strategies adopted by them to sustain and strengthen their positions in the market. Some of the major players operating in this market are Medtronic, Stryker Corporation, Johnson & Johnson, Terumo Corporation, Penumbra, Inc., Abbott Laboratories, Merit Medical Systems, Inc., W. L. Gore & Associates, Inc., Microport Scientific Corporation, Medikit Co., Ltd., Cook, UreSil, LLC and, Boston Scientific Corporation among other companies.